0001179110-20-004529.txt : 20200402 0001179110-20-004529.hdr.sgml : 20200402 20200402171721 ACCESSION NUMBER: 0001179110-20-004529 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200331 FILED AS OF DATE: 20200402 DATE AS OF CHANGE: 20200402 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dreier Ashley CENTRAL INDEX KEY: 0001614957 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36568 FILM NUMBER: 20770180 MAIL ADDRESS: STREET 1: 15 W. SCENIC POINTE DR., STE. 100 CITY: DRAPER STATE: UT ZIP: 84020 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HEALTHEQUITY, INC. CENTRAL INDEX KEY: 0001428336 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 0131 BUSINESS ADDRESS: STREET 1: 15 WEST SCENIC POINTE DRIVE STREET 2: SUITE 100 CITY: DRAPER STATE: UT ZIP: 84020 BUSINESS PHONE: 801-727-1000 MAIL ADDRESS: STREET 1: 15 WEST SCENIC POINTE DRIVE STREET 2: SUITE 100 CITY: DRAPER STATE: UT ZIP: 84020 FORMER COMPANY: FORMER CONFORMED NAME: HEALTHEQUITY INC DATE OF NAME CHANGE: 20080227 4 1 edgar.xml FORM 4 - X0306 4 2020-03-31 0 0001428336 HEALTHEQUITY, INC. HQY 0001614957 Dreier Ashley C/O HEALTHEQUITY, INC. 15 W. SCENIC POINTE DR., STE. 100 DRAPER UT 84020 0 1 0 0 Executive, VP, CTO and CIO Common Stock 2020-03-31 4 A 0 6121 0 A 34913 D Common Stock 2020-03-31 4 A 0 4528 0 A 39441 D Common Stock 2020-03-31 4 A 0 13351 0 A 52792 D Stock Option (right to buy) 24.36 2026-03-23 Common Stock 16250 16250 D Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest as to 6,121 shares on the date of the meeting of the Company's compensation committee to be held in the first quarter of the fiscal year ended January 31, 2022. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest as to 4,528 shares on the date of the meeting of the Company's compensation committee to be held in the first quarter of the fiscal year ended January 31, 2023. The option is immediately exercisable. /s/ Ashley Dreier 2020-04-02